Sintim, Herman O

Back to all technologies

Innovations

Innovation Title Categories Lead Inventor
STING Antagonists for Treating Inflammatory Diseases and Diseased States
2023-SINT-70181
  1. Pharmaceuticals
  2. Biotechnology
Sintim, Herman O
Kinase Inhibitors for Treating Cancer, Inflammation, and Neurological Diseases
2022-SINT-69859
  1. Pharmaceuticals
Sintim, Herman O
Dual Inhibitors of MNK1/2 and p706SK as Potent Anticancer Drugs for Solid Tumors
2022-SINT-69726
  1. Pharmaceuticals
Sintim, Herman O
Phosphodiesterase Inhibitor to Combat Mycobacterium Tuberculosis
2021-SINT-69252
  1. Pharmaceuticals
Sintim, Herman O
New Method for Synthesizing HSN608 Anticancer Agent, HSN608s
2020-THOM-69095
  1. Chemistry and Chemical Analysis
  2. Pharmaceuticals
Thompson, David H
Kinase Inhibitors Optimized for Lung, Pancreatic, and Colon Cancer Therapy
2020-SINT-69073
  1. Pharmaceuticals
Sintim, Herman O
Compounds with Combined Cancer Drug Scaffolds Inhibit Cancer Cell Proliferation at Nanomolar Concentrations
2020-SINT-69102
  1. Pharmaceuticals
Sintim, Herman O
Bactericidal and Bacteriostatic Agents against Drug-Resistant Bacteria
2019-SINT-68535
  1. Pharmaceuticals
Sintim, Herman O
Anti-Angiogenesis Compound Targets Laminin Receptor in Cancer Cells
2017-FIGU-67894
  1. Pharmaceuticals
  2. Medical/Health
Figueiredo, Marxa L
Antibacterial Agents Against Methicillin- and Vancomycin-Resistant Bacteria
2018-SINT-68199
  1. Biotechnology
  2. Medical/Health
Sintim, Herman O

Details

Dr. Herman O. Sintim is the Drug Discovery Professor of Chemistry – Organic Chemistry/Chemical Biology at Purdue University. He received his B.S. at the University College London and his Ph.D. from the University of Oxford. Dr. Sintim has received many awards over his career, including the Sigma Xi Distinguished Lecturer award in 2015, the Allen Angerio Award for Excellence in Faculty Mentorship in 2010, and the NSF Career Award in 2008, to name a few. His research interests include anticancer agents, chemical biology of bacterial communication, virulence factors production, biofilm formation, antibiotics with novel modes of action, catalytic cycle of total synthesis of complex bioactive molecules, new reaction methodologies, new DNA nanostructures, and machines for bioanalyte detection.

For additional information, visit Dr. Sintim's Purdue webpage: website: https://www.chem.purdue.edu/people/directory/faculty/details/118
or his Sintim Research Group website: https://sites.google.com/site/sintimgrouphomepage/